End Stage Renal Disease
Conditions
Interventions
A:Changfu dialysate CAPD 6L/d, three times a day
BA:Baxter dialysate CAPD 6L/d, three times a day
C:Changfu dialysate CAPD 8L/d, four times a day
D:Baxter dialysate CAPD 8L/d, four times a day
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75, male or female; 2. ESRD patients undergo CAPD for >=30days; 3. Sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Acute renal failure; 2. Awaiting kidney transplantation; 3. Hemodialysis; 4. Exit site infection or tunnel infection; 5. Presenting 2/3 of the following: (1) drainage fluid WBC > 100/mm3; (2) abdomenal pain; (3) culture positive/ Gram stain positive in drainage fluid; 6. Anti-HIV positive; 7. Allergic to components of dialysate; 8. Active, residual malignant tumor, or systemic infection, liver cirrhosis, severe congestive heart failure, anemia(Hb10mg/dl; 9. Poor compliance; 10. Pregnant or lactating; 11. Any cirrcumstances when patients are believed unsuitable for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of Kt/V from baseline;Change of Ccr from baseline; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of ultrafiltration from baseline;Change of eGFR from baseline;Change of nPCR from baseline; | — |
Countries
China
Contacts
Public ContactXiangmei Chen
Outcome results
None listed